<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-043306</identifier>
<setSpec>0210-5691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Utility of inhaled nitric oxide in patient with acute respiratory distress syndromeand un-operated Fallot's tetralogy</dc:title>
<dc:description xml:lang="en">Utility of inhaled nitric oxide in the treatment of acute respiratory distress syndrome (ARDS) with pulmonary hypertension (PHT) is controversial and there are few studies in the literature that evaluate its effects during prolonged administration. We analyze the case of a 45 day old male patient with un-operated Fallot's tetralogy who developed ARDS and PHT with non-cardiac cause, that required prolonged mechanical ventilation (30 days) and administration of inhaled nitric oxide (INO). Before the INO, the oxygenation index was 19, and at a few minutes of its application it decreased to 15. The patient developed a dependence on INO, tolerating its gradual weaning. Administration could be interrupted at 27 days on onset. We did not observe toxic effects during the administration of INO</dc:description>
<dc:creator>Cruz-Moreno, J. de la</dc:creator>
<dc:creator>Expósito-Montes, J. F</dc:creator>
<dc:creator>Alados-Arboledas, F. J</dc:creator>
<dc:creator>Millán-Miralles, L</dc:creator>
<dc:creator>González-Rivera, F</dc:creator>
<dc:creator>Santiago-Gutiérrez, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La utilidad del óxido nítrico inhalado en el tratamiento del síndrome de distrés respiratorio agudo (SDRA) con hipertensión pulmonar (HPP) es controvertida y hay pocos estudios en la literatura que evalúen sus efectos durante una administración prolongada. Analizamos el caso de un paciente de 45 días de vida con tetralogía de Fallot no intervenida, que desarrolló SDRA e HPP de causa no cardíaca, que precisó ventilación mecánica prolongada (30 días) y administración de óxido nítrico inhalado (ONI). Antes del ONI el índice de oxigenación era 19 y a los pocos minutos de su aplicación descendió a 15. El paciente desarrolló dependencia del ONI, tolerando un destete gradual, pudiendo interrumpir la administración a los 27 días de su inicio. No observamos efectos tóxicos durante la administración del ONI</dc:description>
<dc:source>Med. intensiva (Madr., Ed. impr.);30(1): 23-25, ene. 2006. tab</dc:source>
<dc:identifier>ibc-043306</dc:identifier>
<dc:title xml:lang="es">Utilidad del óxido nítrico inhalado en paciente con síndrome de distrés respiratorio agudo y tetralogía de Fallot no intervenida</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d9753^s22000</dc:subject>
<dc:subject>^d7155^s22057</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d12548^s22012</dc:subject>
<dc:subject>^d12548^s22057</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d12541^s22074</dc:subject>
<dc:subject>^d19055</dc:subject>
<dc:subject>^d14150^s22012</dc:subject>
<dc:subject>^d14150^s22057</dc:subject>
<dc:type>article</dc:type>
<dc:date>200601</dc:date>
</metadata>
</record>
</ibecs-document>
